ECOR — electroCore,. Share News
0.000.00%
Last trade - 00:00- $65.04m
- $62.90m
- $32.03m
electroCore, Inc. reports results for the quarter ended in September - Earnings Summary
electroCore, Inc. expected to post a loss of 7 cents a share - Earnings Preview
Brief: Electrocore Says Gammacore Non-Invasive Vagus Nerve Stimulation Improves Neurobehavioral Outcomes For Brain Injury
Brief: Electrocore, Inc. - QTRLY Loss Per Share $0.08
Brief: Electrocore Provides Select Second Quarter 2022 Financial Guidance
Brief: electrocore, Inc. Announces Study Of Gammacore Sapphire™ For The Treatment Of Post-Covid Syndrome
Brief: ElectroCore Announces Listing Transfer To Nasdaq Capital Market
Brief: electroCore Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers
electroCore, Inc. reports results for the quarter ended in March - Earnings Summary
Brief: Electrocore Announces Record First Quarter 2022 Financial Results
electroCore, Inc. expected to post a loss of 7 cents a share - Earnings Preview
Brief: GammaCore nVNS Selected For Department Of Defense BOOST Program
Brief: electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance
ElectroCore up on license deal with Japan's Teijin
electroCore, Inc. reports results for the quarter ended in December - Earnings Summary
Brief: Electrocore Announces Fourth Quarter And Full Year 2021 Financial Results
Brief: ElectroCore Announces Changes To Its Board Of Directors
electroCore, Inc. expected to post a loss of 7 cents a share - Earnings Preview
Brief: Electrocore Inc says relative ischemic lesion growth decreased by 65.9% with NVNS vs SHAM treatment.